Tonix Pharmaceuticals
Price & Volume
Stats
See moreOpen | $7.90 |
Previous Close | $8.18 |
Day Range | $7.58-$7.91 |
52W Range | $7.86-$1,221.76 |
Market Cap | $45.7M |
Shares Short | 333,835 |
Financials
See moreRevenue (12 Mos) | $11.2M |
Revenue Growth (YoY) | -29.3% |
Gross Profit (12 Mos) | $2.3M |
Diluted EPS | -$8,039 |
News
See moreYahoo Finance • 21 days ago
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
Yahoo Finance • 22 days ago
Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases
Yahoo Finance • 24 days ago
Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference
Yahoo Finance • 25 days ago
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
About
CEO | Dr. Seth Lederman M.D. |
CFO | Mr. Bradley Saenger CPA |
Address | 26 Main Street, Chatham, NJ, United States, 07928 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 103 |
